MG
SILK

Michael Gelband’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Michael Gelband’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-15,000
Closed -$1.01M – 2474
2020
Q3 		$1.01M Buy
+15,000
New +$819K 0.02% 677

Other funds holding SILK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Michael Gelband's SILK Position: Q2 2024 in Review

Michael Gelband sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2024, closing a stake of 26,796 shares — an estimated $491K sold.

Michael Gelband first reported a position in SILK in Q3 2020 and held it in 9 quarters. The position peaked at $11.5M in Q3 2023. 172 funds tracked by Wall St. Rank hold SILK as of Q2 2024.

  • Michael Gelband reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Michael Gelband sold 26,796 Silk Road Medical, Inc. Common Stock shares in Q2 2024, an estimated $491K.
  • Michael Gelband first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Michael Gelband's Silk Road Medical, Inc. Common Stock position peaked at $11.5M in Q3 2023.
  • 172 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.